These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Transient ischaemic attack associated with the new contraceptive Yasmin. Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284 [No Abstract] [Full Text] [Related]
26. The Risk of MI and Ischemic Stroke with Combined Oral Contraceptives. Nettleton W; King V Am Fam Physician; 2016 Nov; 94(9):691-692. PubMed ID: 27929248 [No Abstract] [Full Text] [Related]
34. Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. Hernádi L; Marr J; Trummer D; De Leo V; Petraglia F Contraception; 2009 Jul; 80(1):18-24. PubMed ID: 19501211 [TBL] [Abstract][Full Text] [Related]
35. Yasmin advert withdrawn--why and how. Drug Ther Bull; 2003 Mar; 41(3):17-8. PubMed ID: 12683099 [TBL] [Abstract][Full Text] [Related]
37. [Modification of tear film break-up time by hormonal contraceptives]. Christ T; Marquardt R; Stodtmeister R; Pillunat LE Fortschr Ophthalmol; 1986; 83(1):108-11. PubMed ID: 3710337 [No Abstract] [Full Text] [Related]
38. Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives. Loughlin J; Seeger JD; Eng PM; Foegh M; Clifford CR; Cutone J; Walker AM Contraception; 2008 Nov; 78(5):377-83. PubMed ID: 18929734 [TBL] [Abstract][Full Text] [Related]
39. Genital cancer and oral contraceptives. The good news! Skouby SO Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):327-9. PubMed ID: 19117249 [No Abstract] [Full Text] [Related]
40. Is Yasmin as safe as other contraceptive pills? Mira Y; Morata C; Vayá A; Ferrando F; Contreras T; Aznar J Clin Appl Thromb Hemost; 2006 Jul; 12(3):378-9. PubMed ID: 16959696 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]